WITHDRAWNNA

Evaluating Treatment Response in Laryngo-Pharyngeal Reflux

NCT01328392•University of Washington

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Laryngo-pharyngeal Reflux

Interventions

Dexlansoprazole

Locations

1

United States

Locations (1)

University of Washington

Seattle, Washington, United States

Key Dates

Start Date

May 1, 2011

Primary Completion Date

April 1, 2012

Completion Date

April 1, 2012

Last Updated

July 5, 2017

Sponsors

Lead Sponsor

University of Washington

Collaborators

Takeda Pharmaceuticals North America, Inc.

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 5, 2017Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions